Amylyx Pharmaceuticals, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cambridge, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Amylyx Pharmaceuticals, Inc. has filed 414 SEC EDGAR filings since 17 Nov 2015

SEC filing history

Showing 201-225 of 414 matching filings.

Per page
25
Current page
9
4

4

Filing date
07 Mar 2024
Reporting date
05 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
28 Feb 2024
Reporting date
26 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
28 Feb 2024
Reporting date
26 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
28 Feb 2024
Reporting date
26 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
28 Feb 2024
Reporting date
26 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
27 Feb 2024
Reporting date
23 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-277274

S-8

Filing date
22 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-93265

SC 13G/A

Filing date
14 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-93265

SC 13G/A filing

Filing date
14 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-93265

AMYLYX PHARMACEUTICALS, INC.

Filing date
14 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-93265

SCHEDULE 13G/A

Filing date
13 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-93265

SC 13G filing

Filing date
29 Jan 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
29 Jan 2024
Reporting date
25 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
18 Jan 2024
Reporting date
16 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
11 Jan 2024
Reporting date
09 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
11 Jan 2024
Reporting date
09 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
11 Jan 2024
Reporting date
09 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
11 Jan 2024
Reporting date
09 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
29 Dec 2023
Reporting date
27 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
20 Dec 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
19 Dec 2023
Reporting date
15 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
19 Dec 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-93265

AMYLYX PHARMACEUTICALS, INC.

Filing date
11 Dec 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .